[Peculiar secretory activity of endometrial cancer cells during progestational therapy].
Effect of progestagen-norsteroids on the cells of endometrial carcinoma was studied. It was established that as an effect of treatment with large doses of progestagen (100 mg/day) in about 4--6 weeks carcinoma cells show a peculiar increased secretory activity. It seems likely, that this secretory activity proceeds on the account of the growth-potencial of tumour cells. Thus, as a result the growth of the tumour ceases, or in optimal cases stops.
D000230:Adenocarcinoma / Q000378:metabolism* / Q000648:ultrastructure; D004717:Endometrium / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure*; D005260:Female; D006801:Humans; D009640:Norethindrone / Q000494:pharmacology / Q000627:therapeutic use*; D012636:Secretory Rate / Q000187:drug effects; D014594:Uterine Neoplasms / Q000378:metabolism* / Q000648:ultrastructure
D009640:Norethindrone
Sajátos szekréciós tevékenység az endometrium carcinoma sejtjeiben progesztatív kezelés kapcsán.